Notable Guests
JC
Jean-Nicolas Cornu
2x
JC
Jean Cunningham
2x
MD
Mary Dunn
2x
CK
Celeste Kirschner
2x
AM
Amy Pearlman, MD
1x
AM
Andrew Peterson, MD
1x
AM
Adanma Ayanambakkam, MD
1x
CM
Cameron Jones, MD
1x
AF
Aleece Fosnight
1x
BM
Brian Mazzarella, MD
1x
CM
Chiara Mercinelli
1x
DK
Daniel S. Kellner
1x
DV
Davis Viprakasit
1x
DM
Declan Murphy
1x
AJ
Angela Jia
1x
Recent Episodes
✨
Dr. Andino explains surgical considerations for ischemic priapism.
✨
Dr. Andrews reviews PSMA-PET radiopharmaceuticals for prostate cancer.
Jack R. Andrews, MD
✨
Discuss study design and evidence gaps for NAD+.
✨
NeoBLAST uses imaging, TURBT, and ctDNA for bladder-sparing surveillance.
Marie-Pier St-Laurent
✨
Urologists should consider IVF cycle context for bladder symptoms.
Aleece Fosnight
✨
Rezūm improved BPO symptoms and quality of life at 1 year.
✨
Suction technology enhances stone clearance in URS.
✨
Testosterone therapy is not linked to increased prostate cancer risk.
✨
Decipher classifier predicted metastasis risk in intermediate-risk prostate cancer.
✨
Dr. Clark reviews AUA NMIBC guideline updates.
Peter E. Clark, MD
✨
Dr. Sfakianos explains ctDNA's role in bladder cancer trials.
John Sfakianos, MD
✨
Dr. Mazzarella reviews prostate cancer landscape.
Brian Mazzarella, MD
✨
Dr. Armine K. Smith discusses sexual health in bladder cancer care.
✨
Rezūm showed superior BPH symptom improvement vs. combination pharmacotherapy at 1 year.
✨
Enfortumab vedotin plus pembrolizumab showed strongest EFS, OS, and PCR improvements.
Chiara Mercinelli
The UroOnc Minute: Neoadjuvant Therapy Before Radical Prostatectomy, With Isaac Y. Kim, MD, PhD, MBA
✨
Discussed neoadjuvant therapy data before prostatectomy.
✨
Addressed barriers to PSMA-PET imaging access.
Juan Gomez Rivas, MD
✨
Urodynamics evolved from early neurophysiology and pressure-flow research.
Sasha Vereecken
✨
Modest increases in urine volume can reduce kidney stone recurrence.
Jonathan Harper, MD
✨
Patient selection for Aquablation considers prostate size and anatomy.
Cameron Jones, MD